An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses.

Humans Animals Mice HIV-1 / genetics Interferon Type I Vaccinia virus / genetics Adjuvants, Immunologic CD8-Positive T-Lymphocytes Immunity Ubiquitins / genetics Cytokines
HIV IFN ISG15 Modify Vaccinia virus Ankara adjuvant inmunity vaccine

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2023
Historique:
received: 15 03 2023
accepted: 17 04 2023
medline: 15 6 2023
pubmed: 14 6 2023
entrez: 14 6 2023
Statut: epublish

Résumé

The

Identifiants

DOI: 10.3389/fcimb.2023.1187193 PMID: 37313341 PMC: PMC10258332
pubmed: 37313341
doi: 10.3389/fcimb.2023.1187193
pmc: PMC10258332
doi:

Substances chimiques

Interferon Type I 0
Adjuvants, Immunologic 0
ISG15 protein, human 60267-61-0
Ubiquitins 0
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1187193

Informations de copyright

Copyright © 2023 Falqui, Perdiguero, Coloma, Albert, Marcos-Villar, McGrail, Sorzano, Esteban, Gómez and Guerra.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Immunol. 1996 Nov 1;157(9):4100-8
pubmed: 8892645
Front Cell Dev Biol. 2021 Nov 25;9:788410
pubmed: 34901029
J Gen Virol. 1998 Feb;79 ( Pt 2):347-52
pubmed: 9472619
J Immunol. 2018 Jul 15;201(2):604-614
pubmed: 29891555
J Virol. 2016 Jan 13;90(7):3428-38
pubmed: 26763998
J Gen Virol. 1998 May;79 ( Pt 5):1159-67
pubmed: 9603331
Viruses. 2018 Nov 13;10(11):
pubmed: 30428561
Cell Res. 2013 Feb;23(2):173-5
pubmed: 22964713
Curr Opin HIV AIDS. 2016 Nov;11(6):585-592
pubmed: 27607594
PLoS One. 2010 Aug 24;5(8):e12395
pubmed: 20811493
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):211-5
pubmed: 8552607
J Biol Chem. 1996 Jan 5;271(1):324-30
pubmed: 8550581
Biochem Biophys Res Commun. 2003 Sep 26;309(3):533-9
pubmed: 12963022
J Virol. 2010 Aug;84(16):8141-52
pubmed: 20534857
Vaccines (Basel). 2020 Feb 06;8(1):
pubmed: 32041218
Biomolecules. 2020 Nov 15;10(11):
pubmed: 33203188
J Virol. 2014 Mar;88(6):3392-410
pubmed: 24390336
J Virol. 2014 May;88(10):5511-23
pubmed: 24599993
Nat Microbiol. 2021 Apr;6(4):467-478
pubmed: 33727702
Viruses. 2014 Jul 17;6(7):2735-61
pubmed: 25036462
ACS Infect Dis. 2020 Aug 14;6(8):2099-2109
pubmed: 32428392
PLoS One. 2013 Jun 27;8(6):e66894
pubmed: 23826170
Science. 1983 May 20;220(4599):868-71
pubmed: 6189183
Sci Signal. 2021 Aug 24;14(697):
pubmed: 34429383
J Biol Chem. 2002 Apr 26;277(17):14703-11
pubmed: 11854279
Viruses. 2020 Jan 24;12(2):
pubmed: 31991671
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1440-5
pubmed: 16434471
ChemTexts. 2022;8(2):12
pubmed: 35287314
J Virol. 2000 Aug;74(16):7651-5
pubmed: 10906221
Nat Commun. 2016 Sep 02;7:12754
pubmed: 27587337
Vaccine. 2007 Apr 12;25(15):2863-85
pubmed: 17113200
J Immunol. 2010 May 15;184(10):5777-90
pubmed: 20385878
Nature. 2020 Nov;587(7835):657-662
pubmed: 32726803
Trends Immunol. 2009 Jan;30(1):23-32
pubmed: 19059004
PLoS One. 2015 Nov 06;10(11):e0141456
pubmed: 26544853
Nature. 1979 Jun 7;279(5713):523-5
pubmed: 571963
Mol Ther. 2015 Oct;23(10):1653-62
pubmed: 26122932
Viruses. 2015 Apr 07;7(4):1726-803
pubmed: 25853483
J Interferon Cytokine Res. 2004 Nov;24(11):647-54
pubmed: 15684817
Nat Rev Microbiol. 2018 Jul;16(7):423-439
pubmed: 29769653
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
J Virol. 2006 Jun;80(12):6033-47
pubmed: 16731942
Curr Protein Pept Sci. 2021;22(1):19-28
pubmed: 33292152
J Immunol. 2020 Apr 15;204(8):2110-2121
pubmed: 32169846
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2253-8
pubmed: 20133869
Methods Mol Biol. 2018;1784:35-49
pubmed: 29761386
J Virol. 2020 Dec 22;95(2):
pubmed: 33115866
J Biol Chem. 1992 Apr 15;267(11):7806-13
pubmed: 1373138
J Immunol. 1991 Apr 1;146(7):2280-4
pubmed: 2005397
Blood. 2007 Jan 15;109(2):619-25
pubmed: 16973959
Elife. 2015 Aug 11;4:
pubmed: 26259872
PLoS Pathog. 2008 Jul 04;4(7):e1000096
pubmed: 18604270
J Gen Virol. 2007 Sep;88(Pt 9):2473-2478
pubmed: 17698656
AIDS Res Ther. 2017 Sep 12;14(1):43
pubmed: 28893282
J Virol. 2006 Jul;80(13):6318-23
pubmed: 16775319
Cancer Res. 2002 Jun 15;62(12):3453-8
pubmed: 12067988
J Biol Chem. 2005 Jul 22;280(29):27356-65
pubmed: 15917233
J Biol Chem. 1987 Aug 15;262(23):11315-23
pubmed: 2440890
AIDS Res Hum Retroviruses. 2008 Feb;24(2):195-206
pubmed: 18240957
PLoS One. 2010 Jun 30;5(6):e11406
pubmed: 20613977
Science. 2012 Sep 28;337(6102):1684-8
pubmed: 22859821
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3974-9
pubmed: 18305167
Front Immunol. 2020 Dec 23;11:594775
pubmed: 33424843
PLoS One. 2011;6(8):e24244
pubmed: 21909386
J Mol Biol. 2013 Dec 13;425(24):4995-5008
pubmed: 24095857
Cancer Lett. 2018 Dec 1;438:52-62
pubmed: 30213559
J Virol. 2013 Jul;87(13):7282-300
pubmed: 23596307
Nat Immunol. 2021 Nov;22(11):1416-1427
pubmed: 34663977
PLoS Pathog. 2013;9(10):e1003632
pubmed: 24137104
Mol Immunol. 2007 Mar;44(7):1483-9
pubmed: 17052755
Mol Cell. 2017 Nov 2;68(3):581-590.e5
pubmed: 29100055
J Virol. 2014 Mar;88(6):3527-47
pubmed: 24403588
J Biol Chem. 2004 Apr 30;279(18):18178-87
pubmed: 14976209

Auteurs

Michela Falqui (M)

Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.

Beatriz Perdiguero (B)

Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Rocio Coloma (R)

Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.

Manuel Albert (M)

Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.

Laura Marcos-Villar (L)

Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Joseph Patrick McGrail (JP)

Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.

Carlos Óscar S Sorzano (CÓS)

Biocomputing Unit and Computational Genomics, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Mariano Esteban (M)

Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Carmen Elena Gómez (CE)

Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Susana Guerra (S)

Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Eucaryotes › Animaux › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Lentivirus › Lentivirus des primates › VIH (Virus de l'Immunodéficience Humaine) › VIH-1 (Virus de l'Immunodéficience Humaine de type 1) › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interférons › Interféron de type I › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Virus › Virus à ADN › Poxviridae › Chordopoxvirinae › Orthopoxvirus › Virus de la vaccine › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Adjuvants immunologiques › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Ubiquitines › An MVA-based vector expressing cell-free ISG15...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › An MVA-based vector expressing cell-free ISG15...